Follow the Granules India Limited share price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Granules India Limited has logged 19 insider filings. Market capitalisation: €206.7bn. The latest transaction was reported on 1 October 2021 (Purchase). Among the most active insiders: K. B. Sankar Rao. All data is free.
19
Insider Decl.
n/a
Thresholds
€843,555
8 ops.
Buy Volume
€2m
11 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Granules India Limited Strong Buy (bullish), based on 8 analysts. Average price target: ₹919.13.
11Σ signal
Buys €843,555€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,107 of 28,717 companies
56.0
score / 100
Value
40
Quality
72
FCF yld1.1%
Earn yld2.9%
EV/EBITDA19.2x
ROE14%
Gross mgn62%
Net mgn11%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
124,000 shares@ ₹324.34560.0003% mcap32.2% of flowEquity SharesSEBI:74a1a0f479cd1126ea28b5f65de57f3e89e784af
19 of 19 declarations
About Granules India Limited
Granules India Limited is a pharmaceutical company based in India, specializing in the manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.